Oct 31, 2024 08:39AM
Aug 1, 2024 07:00AM
Jul 1, 2024 07:30AM
Jul 1, 2024 07:30AM
Feb 7, 2024 07:00AM
Oct 31, 2023 07:00AM
Sep 14, 2023 08:31AM Neurocrine Biosciences (NBIX) Announces U.S. FDA Accepts New Drug Application for INGREZZA® (valbenazine) Oral Granules Sprinkle Formulation
Sep 14, 2023 08:30AM
Aug 1, 2023 07:00AM
May 19, 2023 08:30AM
May 19, 2023 08:30AM
Feb 6, 2023 07:30AM
Dec 22, 2022 04:01PM
Dec 22, 2022 04:01PM Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application for Valbenazine as a Treatment for Chorea Associated with Huntington Disease
Mar 9, 2021 07:48AM
Apr 3, 2020 08:33AM
Apr 3, 2020 08:30AM
Feb 24, 2020 06:56AM
Jan 13, 2020 06:00AM
Jan 12, 2020 06:30PM
Nov 4, 2019 04:01PM Neurocrine Biosciences Reports Third Quarter 2019 Financial Results
Jul 29, 2019 04:01PM
Jul 10, 2019 04:11PM
Jul 10, 2019 04:10PM
May 1, 2018 07:40AM
Apr 30, 2018 04:01PM
Apr 27, 2018 08:00AM
Apr 10, 2018 08:15AM AbbVie (ABBV), Neurocrine Biosciences (NBIX) Announce PDUFA Target Date of Q3 2018 for Elagolix in Endometriosis-Associated Pain
Apr 10, 2018 08:15AM
Feb 14, 2018 06:21AM
Feb 13, 2018 04:01PM
Jan 26, 2018 09:05AM
Jan 8, 2018 05:45AM
Jan 7, 2018 01:00PM
Nov 1, 2017 04:01PM Neurocrine Biosciences Reports Third Quarter 2017 Results
Oct 27, 2017 07:01AM
Oct 27, 2017 07:00AM
Aug 3, 2017 04:01PM
Jul 5, 2017 06:29AM
Mar 21, 2017 09:01AM
Mar 21, 2017 08:59AM
Mar 17, 2017 07:23AM Neurocrine Biosciences (NBIX): KOL Call Implies Ingrezza Approval in '17 - Needham
Mar 7, 2017 06:18AM
Feb 15, 2017 07:58AM
Feb 14, 2017 04:01PM
Feb 10, 2017 06:19AM
Jan 27, 2017 06:32AM
Jan 6, 2017 09:29AM
Jan 6, 2017 07:44AM Needham & Company Remains Bullish on Neurocrine Biosciences (NBIX) Following FDA Announcement
Jan 6, 2017 06:25AM

15,418 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All